Piperazinyl pyrimidine derivatives as potent gamma-secretase modulators.

[1]  Chaomin Li,et al.  A practical strategy for the synthesis of 2-dialkylamino-4-arylamino-6-aminopyrimidines , 2009 .

[2]  D. Melton,et al.  Direct regulation of intestinal fate by Notch. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Nadin,et al.  Quantitative Measurement of Changes in Amyloid-β(40) in the Rat Brain and Cerebrospinal Fluid following Treatment with the γ-Secretase Inhibitor LY-411575 [N2-[(2S)-2-(3,5-Difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-l-alaninamide] , 2005, Journal of Pharmacology and Experimental Therapeutics.

[4]  Sanjiv S Gambhir,et al.  Firefly luciferase enzyme fragment complementation for imaging in cells and living animals. , 2005, Analytical chemistry.

[5]  W. Pear,et al.  Notch and the immune system. , 2003, Immunity.

[6]  A. Hofman,et al.  Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. , 2001, The New England journal of medicine.

[7]  Rong Wang,et al.  A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity , 2001, Nature.

[8]  L. Beckett,et al.  Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.

[9]  M. Shearman,et al.  Quantitation of amyloid-β peptides in biological milieu using a novel homogeneous time-resolved fluorescence (HTRF) assay , 2000, Journal of Neuroscience Methods.

[10]  K. Ashe,et al.  Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease , 2000, The Journal of Neuroscience.

[11]  D. Dickson,et al.  The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.

[12]  K. Beyreuther,et al.  Generation of βA4 from the amyloid protein precursor and fragments thereof , 1993 .

[13]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[14]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[15]  B. Imbimbo Therapeutic Potential of γ -Secretase Inhibitors and Modulators , 2008 .

[16]  D. Beher γ-Secretase Modulation and its Promise for Alzheimers Disease: a Rationale for Drug Discovery , 2008 .

[17]  I. Peretto,et al.  Gamma-secretase modulation and its promise for Alzheimer's disease: a medicinal chemistry perspective. , 2008, Current topics in medicinal chemistry.